- Home
- KPTI vs BSL Comparison
KPTI vs BSL Comparison
Compare KPTI & BSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KPTI | BSL |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.6M | 167.1M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | KPTI | BSL |
|---|---|---|
| Price | $5.34 | $12.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $15.33 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 61.4K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,067,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $46.62 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $3.51 | $12.45 |
| 52 Week High | $10.99 | $14.35 |
Technical Indicators
Market Signals| Indicator | KPTI | BSL |
|---|---|---|
| Relative Strength Index (RSI) | 29.62 | 37.67 |
| Support Level | $3.93 | $12.45 |
| Resistance Level | $6.82 | $12.94 |
| Average True Range (ATR) | 0.86 | 0.14 |
| MACD | -0.36 | 0.02 |
| Stochastic Oscillator | 9.41 | 41.18 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About BSL Blackstone
Blackstone Senior Floating Rate Term Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. The fund also invests in second-lien loans and high yield bonds and employs financial leverage which may increase the risk to the Fund.